FDA Gives First Approval for Novartis’ Iptacopan, a Revolutionary Oral Treatment for Rare Blood Disorder PNH
Novartis has received FDA approval for iptacopan, an innovative oral treatment for paroxysmal nocturnal hemoglobinuria (PNH), [...]
Exploring the Potential and Challenges of mRNA Technology in Revolutionizing Flu Vaccines
The article discusses the potential of mRNA technology, popularized during the COVID-19 pandemic, in revolutionizing flu [...]
Navigating Pharmaceutical Sales with Next Best Action 2.0: A Data-Driven Approach
In the ever-evolving pharmaceutical business, the Next Best Action (NBA) approach has emerged as a crucial [...]
Consolidation of US Hospitals Leads to Increased Profits but Not Improved Care Quality, Study Finds
The consolidation of US hospitals increased between 2000 and 2020, with multi-unit hospital systems now owning [...]
UK Biobank Releases Groundbreaking Dataset from Whole Genome Sequencing of 500,000 Participants, Poised to Transform Medical Research
UK Biobank has unveiled a comprehensive dataset from genome sequencing of 500,000 participants, marking a milestone [...]
Samsung Bioepis Set to Launch Stelara Biosimilar in 2025 Amid Challenges for Medicare Price Negotiation Exemption
Samsung Bioepis recently finalized an agreement allowing its Stelara biosimilar, SB17, to launch in February 2025. [...]
Trump Revives ACA Debate, Faces Pushback Amid Biden’s Healthcare Emphasis
Donald Trump has recently reignited the debate over the Affordable Care Act (ACA), also known as [...]
AbbVie Expands Oncology Footprint with $10.1 Billion Acquisition of ImmunoGen
AbbVie, a pharmaceutical giant, announced its plan to acquire ImmunoGen, a clinical-stage biotech company specializing in [...]
Balancing Public Health and Environmental Sustainability: Insights from the Unitaid Report
The recent Unitaid report highlights a complex issue in climate change: the significant environmental impact of [...]
Harvard Researchers Urge Removal of Single Orphan Drug Exemption in Inflation Reduction Act
Biopharma companies are protesting the Inflation Reduction Act's (IRA) pricing negotiations for drugs with multiple orphan [...]
Gilead Sciences’ Kite Pharma Announces Workforce Reduction and Strategy Shift Amid FDA Review
Gilead Sciences' Kite Pharma is reducing its workforce by approximately 7% as part of a business [...]
Pioneering the Path for FDA Approval of Gender-Affirming Hormone Therapies: The Research Institute for Gender Therapeutics’ Groundbreaking Initiative
The Research Institute for Gender Therapeutics (RIGT), a nonprofit organization, is pioneering research to gain FDA [...]
Merck’s Pneumococcal Vaccine V116 Matches Pfizer’s Prevnar 20 in Phase 3 Trial
Merck’s investigational pneumococcal vaccine V116 demonstrated efficacy and safety levels similar to Pfizer’s Prevnar 20 vaccine [...]
NIH Invests $9.7 Million in Research Projects Utilizing All of Us Program Data
The NIH awarded $9.7 million to 26 projects over two years to enhance research using the [...]
Truveta’s Comparative Study on Weight Loss Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Patients
Truveta's new research explored the effectiveness of semaglutide (Ozempic) and tirzepatide (Mounjaro) in weight loss among [...]
Nearly Half of Americans Affected by COVID-19 Misinformation, Study Finds
Almost half of Americans felt their decisions related to COVID-19 were influenced by misinformation, and 43.7% [...]
FDA Launches START Program to Accelerate Development of Therapies for Rare Diseases
The FDA has launched the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) program, applying [...]
Realizing the Potential of Digital Measures in the Shift Towards Value-based Care
The shift towards value-based care in healthcare has renewed interest in using digital measures such as [...]
Pharmaceutical Industry Faces Major Transition as Traditional Commercial Model is Disrupted
The traditional commercial model in pharmaceuticals has been disrupted due to shifts in the healthcare market, [...]
Bayer’s Asundexian Fails in Phase 3 Trial, Impacting 5 Billion Euro Annual Revenue Plan
Bayer's plans to make Asundexian into a 5 billion euro per year product have faced a [...]
Respiratory Viruses Return to Seasonal Patterns After Covid-19 Disruption
During the height of the COVID-19 pandemic, other respiratory viruses such as the flu, RSV, and [...]
U.S. Sees High Levels of Preterm Births and Infant Mortality, Surpassing Global Averages and Peers: March of Dimes Report
Preterm births and infant mortality rates remain a concern in the U.S., as stated in a [...]
Global Vascular Access Devices Market Expected to Grow to Nearly $15 Billion by 2030; Becton Dickinson and 3M Dominate the Market
The global vascular access device market reached a value of $12.5 billion in 2023 and is [...]
Montrose Regional Health Joins Guardian Research Network’s Nationwide Healthcare Research Consortium
Guardian Research Network (GRN) has announced that Montrose Regional Health (MRH), a critical healthcare facility in [...]
Evidation Announces Major Partnership with ‘Our Future Health’ for Multi-Year UK Health Research Program
Evidation, a health-tech company, has announced a significant partnership with Our Future Health, a national health [...]